Form 8-K - Current report:
SEC Accession No. 0001564590-20-054532
Filing Date
2020-11-19
Accepted
2020-11-19 07:10:33
Documents
49
Period of Report
2020-11-19
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arav-8k_20201119.htm 8-K 37513
2 EX-99.1 arav-ex991_149.htm EX-99.1 15173
3 EX-99.2 arav-ex992_28.htm EX-99.2 52883
4 GRAPHIC gmt0juvuw22w000040.jpg GRAPHIC 337936
5 GRAPHIC gmt0juvuw22w000017.jpg GRAPHIC 288469
6 GRAPHIC gmt0juvuw22w000034.jpg GRAPHIC 305907
7 GRAPHIC gmt0juvuw22w000024.jpg GRAPHIC 287021
8 GRAPHIC gmt0juvuw22w000035.jpg GRAPHIC 267929
9 GRAPHIC gmt0juvuw22w000043.jpg GRAPHIC 175161
10 GRAPHIC gmt0juvuw22w000010.jpg GRAPHIC 188224
11 GRAPHIC gmt0juvuw22w000003.jpg GRAPHIC 290640
12 GRAPHIC gmt0juvuw22w000031.jpg GRAPHIC 327556
13 GRAPHIC gmt0juvuw22w000042.jpg GRAPHIC 297737
14 GRAPHIC gmt0juvuw22w000037.jpg GRAPHIC 248133
15 GRAPHIC gmt0juvuw22w000019.jpg GRAPHIC 326573
16 GRAPHIC gmt0juvuw22w000030.jpg GRAPHIC 225411
17 GRAPHIC gmt0juvuw22w000045.jpg GRAPHIC 263158
18 GRAPHIC gmt0juvuw22w000009.jpg GRAPHIC 297871
19 GRAPHIC gmt0juvuw22w000039.jpg GRAPHIC 341888
20 GRAPHIC gmt0juvuw22w000006.jpg GRAPHIC 318998
21 GRAPHIC gmt0juvuw22w000002.jpg GRAPHIC 431598
22 GRAPHIC gmt0juvuw22w000036.jpg GRAPHIC 334783
23 GRAPHIC gmt0juvuw22w000038.jpg GRAPHIC 438537
24 GRAPHIC gt2gstnkw0iu000001.jpg GRAPHIC 2002
25 GRAPHIC gmt0juvuw22w000013.jpg GRAPHIC 251386
26 GRAPHIC gmt0juvuw22w000029.jpg GRAPHIC 231353
27 GRAPHIC gmt0juvuw22w000025.jpg GRAPHIC 253082
28 GRAPHIC gmt0juvuw22w000027.jpg GRAPHIC 146840
29 GRAPHIC gmt0juvuw22w000028.jpg GRAPHIC 287558
30 GRAPHIC gmt0juvuw22w000011.jpg GRAPHIC 387148
31 GRAPHIC gmt0juvuw22w000041.jpg GRAPHIC 181786
32 GRAPHIC gmt0juvuw22w000015.jpg GRAPHIC 246627
33 GRAPHIC gmt0juvuw22w000022.jpg GRAPHIC 445111
34 GRAPHIC gmt0juvuw22w000026.jpg GRAPHIC 301577
35 GRAPHIC gmt0juvuw22w000020.jpg GRAPHIC 332814
36 GRAPHIC gmt0juvuw22w000005.jpg GRAPHIC 106449
37 GRAPHIC gmt0juvuw22w000012.jpg GRAPHIC 327649
38 GRAPHIC gmt0juvuw22w000014.jpg GRAPHIC 362329
39 GRAPHIC gmt0juvuw22w000007.jpg GRAPHIC 509462
40 GRAPHIC gmt0juvuw22w000016.jpg GRAPHIC 270358
41 GRAPHIC gmt0juvuw22w000044.jpg GRAPHIC 228789
42 GRAPHIC gmt0juvuw22w000021.jpg GRAPHIC 440025
43 GRAPHIC gmt0juvuw22w000008.jpg GRAPHIC 351225
44 GRAPHIC gmt0juvuw22w000018.jpg GRAPHIC 349956
45 GRAPHIC gmt0juvuw22w000023.jpg GRAPHIC 434616
46 GRAPHIC gmt0juvuw22w000001.jpg GRAPHIC 303500
47 GRAPHIC gmt0juvuw22w000004.jpg GRAPHIC 275913
48 GRAPHIC gmt0juvuw22w000033.jpg GRAPHIC 243743
49 GRAPHIC gmt0juvuw22w000032.jpg GRAPHIC 464476
  Complete submission text file 0001564590-20-054532.txt   19019814
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 201327060
SIC: 2834 Pharmaceutical Preparations